85
52
Growth Score
-6 pts
Heat Score
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
277596
Chrysea develops nutritional interventions supported by clinical research for anti-aging mechanisms.
- Pedro De Noronha Pissarra: Chief Executive OfficerPast Role: Biotecnol Ltd., Chief Executive Office
- Patrick Keohane: Co-Founder, Chief Medical and Development OfficerPast Role: Akari Therapeutics, Chief Medical Officer
About the Company
Chrysea is aiming to enhance a naturally occurring anti-aging mechanism called autophagy, a process by which cells recycle and get rid of damaged structures, which is essential to maintaining cell health, renewal, and survival by developing accurate healthy lifespan nutritional interventions backed by intensive clinical research. It develops
naturally occurring small compounds and their synthesis methods based on its synthetic biology platform, to fill unmet medical needs related to age-related disorders.
